Advertisement

Mediterranean Diet and Outcomes Among Patients With Advanced Melanoma Receiving Immunotherapy
Posted: 04/19/2023 | By: Melissa E. Fryman, MS

In a report published by Bolte et al in JAMA Oncology, investigators studied the association between habitual diet and response to treatment with immune checkpoint blockade in patients with advanced melanoma.

Question 1 of 5

The research that informed the rationale for this study suggests that many patients with advanced melanoma do not tolerate and/or respond to immune checkpoint blockade treatments due to:

Choose 1

A
Immune-related adverse events
B
Differences in the gut microbiome
C
Differences in body mass index
D
Pre-existing comorbidities

CategoriesView All Quizzes

Tumor Type


Additional Topics



Conference Coverage